The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

8 Mar 2018 16:02

RNS Number : 1791H
Royal Bank of Scotland Group PLC
08 March 2018
 

8 March 2018

The Royal Bank of Scotland Group plc

Legal Entity Identifier: 2138005O9XJIJN4JPN90

 

 

INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY ("PDMRs") IN ACCORDANCE WITH ARTICLE 19 OF THE EU MARKET ABUSE REGULATION 596/2014

 

1. The Royal Bank of Scotland Group plc (the "Company") announces that conditional deferred awards over ordinary shares of £1 each in the Company ("Shares") (ISIN: GB00B7T77214) vested on 7 March 2018 to the PDMRs set out below. The conditional deferred awards were granted under the RBS 2014 Employee Share Plan between March 2015 and March 2017. The number of Shares withheld to meet associated tax liabilities arising on vesting and the number of vested Shares retained by each PDMR is set out below:-

 

Name of PDMR

Position of PDMR

No. of Shares vested

No. of Shares withheld to satisfy associated tax liability

No. of vested Shares retained

Mark Bailie

Chief Operating Officer

118,314

55,608

62,706

Helen Cook

Chief HR Officer

34,143

16,049

18,094

Chris Marks

CEO, NatWest Markets

118,314

55,608

62,706

 

The above transactions took place outside of a trading venue. The market price used to determine the number of Shares withheld to meet associated tax liabilities was £2.61. Vested Shares retained after payment of associated tax liabilities will be subject to a six month retention period.

 

2. The Company announces that conditional long term incentive awards over Shares have been granted on 7 March 2018 under the RBS 2014 Employee Share Plan to the PDMRs set out below. The awards were subject to a pre-grant performance assessment and a further performance assessment will take place at the end of three years. Subject to this pre-vest assessment, awards will be eligible to vest between years 2021 and 2025. Malus provisions will apply up until vest and clawback provisions will apply for a period of seven years from the date of grant, extended to ten years if events are under investigation at the end of the seven year period.

 

Name of PDMR

Position of PDMR

Maximum no. of

Shares eligible to vest

Mark Bailie

Chief Operating Officer

507,710

Helen Cook

Chief HR Officer

225,649

Chris Marks

CEO, NatWest Markets

564,122

Les Matheson

CEO, Personal & Business Banking

394,886

Ross McEwan

Chief Executive

592,328

Simon McNamara

Chief Administrative Officer

394,886

Alison Rose

CEO, Commercial & Private Banking

488,906

Ewen Stevenson

Chief Financial Officer

541,557

David Wheldon

Chief Marketing Officer

206,845

 

The above transactions took place outside of a trading venue. The market price per Share used on the grant of the above awards was £2.659. Vested Shares retained after payment of associated tax liabilities will be subject to a twelve month retention period.

 

3. The Company also announces that it was notified on 6 March 2018 that Frank Dangeard, Non-executive director, purchased 5,000 Shares on that date at a price of £2.626 per Share. The transaction took place on the London Stock Exchange (XLON).

 

4. The Company also announces that it was notified on 8 March 2018 that Les Matheson, CEO, Personal & Business Banking, sold 107,372 Shares on that date at a price of £2.617 per Share. The transaction took place on the London Stock Exchange (XLON).

 

 

 

For further information contact:-

 

RBS Investor RelationsAlexander HolcroftHead of Equity Investor Relations+44 20 7672 1758

 

RBS Media Relations

+44(0)131 523 4205

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFEEVAITIIT
Date   Source Headline
22nd Jul 20202:00 pmRNSChange of Name
16th Jul 20207:00 amRNSIntention to Change Name on 22 July 2020
1st Jul 202012:29 pmRNSDirector/PDMR Shareholding
30th Jun 20204:26 pmRNSTotal Voting Rights
29th Jun 20207:00 amRNSNotice of Redemption
25th Jun 20209:19 amRNSRBSG pricing of US$1.5bn Additional Tier 1 Notes
23rd Jun 20207:00 amRNSChanges to the Alternative Remedies Package
11th Jun 20205:31 pmRNSPublication of Supplementary Prospectus
11th Jun 20208:00 amRNSRBS and NatWest Markets announce appointments
8th Jun 20204:15 pmRNSHolding(s) in Company
8th Jun 20203:38 pmRNSTotal Voting Rights and Capital
8th Jun 20203:20 pmRNSDirector/PDMR Shareholding
29th May 20203:09 pmRNSDirector/PDMR Shareholding
29th May 20202:25 pmRNSTotal Voting Rights
29th May 202012:52 pmRNSDividend Declaration
21st May 202010:15 amRNSAdditional Listing
20th May 20207:04 amRNSRBSG pricing of US$1.6bn of Senior Notes
14th May 20201:00 pmRNSDirector/PDMR Shareholding
13th May 20204:01 pmRNSPublication of Final Terms
12th May 202011:16 amRNSQ1 2020 Pillar 3 Supplement
5th May 20204:57 pmRNSPublication of Supplementary Prospectus
1st May 20204:20 pmRNSPublication of Suppl.Prospcts
1st May 20207:00 amRNSQ1 Interim Management Statement
30th Apr 202012:20 pmRNSTotal Voting Rights
29th Apr 20204:33 pmRNSResult of AGM
29th Apr 20203:01 pmRNSAGM Statement
28th Apr 20203:51 pmRNSDirector/PDMR Shareholding
27th Apr 20204:40 pmRNSSecond Price Monitoring Extn
27th Apr 20204:35 pmRNSPrice Monitoring Extension
27th Apr 20203:58 pmRNSDisclosure of rights attached to equity shares
20th Apr 202012:38 pmRNSDividend Declaration
14th Apr 20204:21 pmRNSVirtual Shareholder Event – 29 April 2020
7th Apr 20204:41 pmRNSSecond Price Monitoring Extn
7th Apr 20204:35 pmRNSPrice Monitoring Extension
6th Apr 20202:14 pmRNSBlock Listing Six Monthly Return
3rd Apr 20204:11 pmRNSAmendment of Final Terms
3rd Apr 20203:24 pmRNSNotice of AGM
2nd Apr 202012:11 pmRNSDirector/PDMR Shareholding
1st Apr 20204:41 pmRNSSecond Price Monitoring Extn
1st Apr 20204:36 pmRNSPrice Monitoring Extension
1st Apr 202011:34 amRNSRoyal Bank of Scotland Group
1st Apr 20207:00 amRNSResponse to Covid-19
26th Mar 20204:42 pmRNSSecond Price Monitoring Extn
26th Mar 20204:37 pmRNSPrice Monitoring Extension
25th Mar 20204:41 pmRNSSecond Price Monitoring Extn
25th Mar 20204:35 pmRNSPrice Monitoring Extension
24th Mar 20204:42 pmRNSSecond Price Monitoring Extn
24th Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 202010:20 amRNSSecond Price Monitoring Extn
20th Mar 202010:16 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.